The added value of contrast-enhanced spectral mammography for the assessment of ...
Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain
27 Jan 2020
Chemotherapy in patients with luminal breast cancer and an intermediate risk rec...
Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France
27 Jan 2020
Preoperative management of operable cT3 cN1 luminal breast cancer: Upfront neoad...
Prof Joseph Gligorov - Paris-Sorbonne University, Paris, France
27 Jan 2020
Dual HER2 blockade in patients with HER2-positive breast cancer after pCR
27 Jan 2020
Triple-positive breast cancer: Systemic management strategies
Prof Pierre Conte - University of Padova, Padova, Italy
27 Jan 2020
Breast cancer in Morocco
Dr Narjiss Berrada - Institut National d'Oncologie, Rabat, Morocco
27 Jan 2020
Updates in the ABC5 guidelines for the treatment of luminal metastatic breast ca...
Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut, Leba...
27 Jan 2020
Current controversies in breast cancer treatment
Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland
27 Jan 2020
Highlights from BGICC 2020
Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
27 Jan 2020
Combining chemotherapy and hormone therapy for the treatment of luminal metastat...
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
27 Jan 2020
Ductal carcinoma in situ, are we over-treating it?
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
27 Jan 2020
An overview of breast cancer in Malaysia
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
27 Jan 2020
